论文部分内容阅读
目的:观察乳糖酸阿奇霉素治疗小儿支气管炎的临床疗效。方法:选取60例小儿支气管炎患者,随机分为观察组和对照组各30例,两组患儿均进行抗病毒、止咳、保持呼吸道通畅等常规综合治疗。在此基础上,观察组患者给予乳糖酸阿奇霉素,对照组给予红霉素注射液。观察两组患儿症状改善情况和体征变化,对比分析两组临床治疗效果。结果:观察组治疗总有效率为93.33%,明显高于对照组的73.33%,差异有统计学意义(P<0.05);观察组患儿发生不良反应4例(13.33%),对照组发生不良反应7例(23.33%),两组不良反应发生率比较差异有统计学意义(P<0.05)。结论:乳酸汤阿奇霉素治疗小儿支气管炎疗效满意,安全性较高,值得临床推广应用。
Objective: To observe the clinical efficacy of azithromycin lactobionate in the treatment of children with bronchitis. Methods: Sixty cases of children with bronchitis were randomly divided into observation group and control group, with 30 cases in each group. The two groups of children were treated with conventional comprehensive therapy such as antivirus, cough prevention and airway maintenance. On this basis, the observation group patients given azithromycin lactobionate, the control group was given erythromycin injection. The improvement of symptoms and signs in both groups were observed, and the clinical effects were compared between the two groups. Results: The total effective rate of the observation group was 93.33%, which was significantly higher than that of the control group (73.33%), the difference was statistically significant (P <0.05); adverse reactions in the observation group were 4 cases (13.33%), There were 7 cases (23.33%) of reactions, the difference of adverse reaction between the two groups was statistically significant (P <0.05). Conclusion: Lactic acid azithromycin treatment of children with bronchitis satisfaction, safety is high, worthy of clinical application.